India Patent Law Challenge By Novartis Endangers Generics, Docs Say
This article was originally published in PharmAsia News
Executive Summary
A drug patent case in India involving Switzerland's Novartis AG threatens to undermine the availability of generic drugs in the developing world, according to a medical charity